University of South Carolina

Charleston, South Carolina 29425

3 studies enrolling now · 8 studies all time

What they study most

Advanced Solid Tumors, Alpha1-Antitrypsin Deficiency, Burns, Embolism and Thrombosis, Growth Hormone Deficiency, Heart Failure, Lupus Nephritis, Peripheral Vascular Disease, Renal Cell Carcinoma, Venous Thrombosis, Wound Heal

Studies at this site

• A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems — Recruiting now
• VIBRANT: VIB4920 for Active Lupus Nephritis — Recruiting now
• A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors — Completed
• DeepView SnapShot Portable (DV-SSP): Device Training Study — Completed
• A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) — Enrolling by invitation
• Genomic Response Analysis of Heart Failure Therapy in African Americans — Completed
• Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer — Completed
• Registry of AngioJet Use in the Peripheral Vascular System — Completed